Biodesix (NASDAQ:BDSX) reported its Q4 earnings results on Friday, March 1, 2024 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Biodesix beat estimated earnings by 9.0%, reporting an EPS of $-0.1 versus an estimate of $-0.11.
Revenue was down $893.33 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 10.0% drop in the share price the next day.
Here's a look at Biodesix's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -0.15 | -0.21 | -0.24 | -0.28 |
EPS Actual | -0.14 | -0.17 | -0.24 | -0.28 |
Revenue Estimate | 14.36M | 11.38M | 8.70M | 10.77M |
Revenue Actual | 13.49M | 11.87M | 9.06M | 908.00M |
To track all earnings releases for Biodesix visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.